TY - JOUR
T1 - Gpr88 Deletion Impacts Motivational Control Without Overt Disruptions to Striatal Dopamine
AU - Spark, Daisy L.
AU - Vermeulen, Michela H.
AU - de la Fuente Gonzalez, Rocío A.
AU - Hatzipantelis, Cassandra J.
AU - Rueda, Patricia
AU - Sepehrizadeh, Tara
AU - De Veer, Michael
AU - Mannoury la Cour, Clotilde
AU - Fornito, Alex
AU - Langiu, Monica
AU - Stewart, Gregory D.
AU - Nithianantharajah, Jess
AU - Langmead, Christopher J.
N1 - Funding Information:
The mutant animals were produced via CRISPR genome editing by the Monash Genome Modification Platform, Monash University, as a node of Phenomics Australia. Phenomics Australia is supported by the Australian Government Department of Education through the National Collaborative Research Infrastructure Strategy, the Super Science Initiative, and the Collaborative Research Infrastructure Scheme.
Funding Information:
This work was partially funded by Les Laboratoires Servier (to PR, RAdlFG, CMlC, ML, GDS, CJL) and supported by National Health and Medical Research Council Project (Grant No. 1104371 [to CJL and JN]) and an Australian Research Council Future Fellowship (Grant No. 140101327 [to JN]).
Funding Information:
This work was partially funded by Les Laboratoires Servier (to PR, RAdlFG, CMlC, ML, GDS, CJL) and supported by National Health and Medical Research Council Project (Grant No. 1104371 [to CJL and JN]) and an Australian Research Council Future Fellowship (Grant No. 140101327 [to JN]). We thank the scientific and technical assistance of the National Imaging Facility, a National Collaborative Research Infrastructure Strategy capability; Monash Biomedical Imaging, Monash University; Ms. Yao Lu, Monash Institute of Pharmaceutical Sciences, Monash University; and Dr. Robyn M. Brown, Florey Institute of Neuroscience and Mental Health. The mutant animals were produced via CRISPR genome editing by the Monash Genome Modification Platform, Monash University, as a node of Phenomics Australia. Phenomics Australia is supported by the Australian Government Department of Education through the National Collaborative Research Infrastructure Strategy, the Super Science Initiative, and the Collaborative Research Infrastructure Scheme. CMlC is a full-time employee of Les Laboratoires Servier. All other authors report no biomedical financial interests or potential conflicts of interest.
Publisher Copyright:
© 2022 The Authors
PY - 2023/10
Y1 - 2023/10
N2 - Background: Disrupted motivational control is a common—but poorly treated—feature of psychiatric disorders, arising via aberrant mesolimbic dopaminergic signaling. GPR88 is an orphan G protein–coupled receptor that is highly expressed in the striatum and therefore well placed to modulate disrupted signaling. While the phenotype of Gpr88 knockout mice suggests a role in motivational pathways, it is unclear whether GPR88 is involved in reward valuation and/or effort-based decision making in a sex-dependent manner and whether this involves altered dopamine function. Methods: In male and female Gpr88 knockout mice, we used touchscreen-based progressive ratio, with and without reward devaluation, and effort-related choice tasks to assess motivation and cost/benefit decision making, respectively. To explore whether these motivational behaviors were related to alterations in the striatal dopamine system, we quantified expression of dopamine-related genes and/or proteins and used [18F]DOPA positron emission tomography and GTPγ[35S] binding to assess presynaptic and postsynaptic dopamine function, respectively. Results: We showed that male and female Gpr88 knockout mice displayed greater motivational drive than wild-type mice, which was maintained following reward devaluation. Furthermore, we showed that cost/benefit decision making was impaired in male, but not female, Gpr88 knockout mice. Surprisingly, we found that Gpr88 deletion had no effect on striatal dopamine by any of the measures assessed. Conclusions: Our results highlight that GPR88 regulates motivational control but that disruption of such behaviors following Gpr88 deletion occurs independently of gross perturbations to striatal dopamine at a gene, protein, or functional level. This work provides further insights into GPR88 as a drug target for motivational disorders.
AB - Background: Disrupted motivational control is a common—but poorly treated—feature of psychiatric disorders, arising via aberrant mesolimbic dopaminergic signaling. GPR88 is an orphan G protein–coupled receptor that is highly expressed in the striatum and therefore well placed to modulate disrupted signaling. While the phenotype of Gpr88 knockout mice suggests a role in motivational pathways, it is unclear whether GPR88 is involved in reward valuation and/or effort-based decision making in a sex-dependent manner and whether this involves altered dopamine function. Methods: In male and female Gpr88 knockout mice, we used touchscreen-based progressive ratio, with and without reward devaluation, and effort-related choice tasks to assess motivation and cost/benefit decision making, respectively. To explore whether these motivational behaviors were related to alterations in the striatal dopamine system, we quantified expression of dopamine-related genes and/or proteins and used [18F]DOPA positron emission tomography and GTPγ[35S] binding to assess presynaptic and postsynaptic dopamine function, respectively. Results: We showed that male and female Gpr88 knockout mice displayed greater motivational drive than wild-type mice, which was maintained following reward devaluation. Furthermore, we showed that cost/benefit decision making was impaired in male, but not female, Gpr88 knockout mice. Surprisingly, we found that Gpr88 deletion had no effect on striatal dopamine by any of the measures assessed. Conclusions: Our results highlight that GPR88 regulates motivational control but that disruption of such behaviors following Gpr88 deletion occurs independently of gross perturbations to striatal dopamine at a gene, protein, or functional level. This work provides further insights into GPR88 as a drug target for motivational disorders.
KW - Dopamine
KW - GPR88
KW - Motivation
KW - Orphan G protein–coupled receptor
KW - Striatum
KW - Touchscreen
UR - http://www.scopus.com/inward/record.url?scp=85150021644&partnerID=8YFLogxK
U2 - 10.1016/j.bpsgos.2022.10.008
DO - 10.1016/j.bpsgos.2022.10.008
M3 - Article
C2 - 37881541
AN - SCOPUS:85150021644
SN - 2667-1743
VL - 3
SP - 1053
EP - 1061
JO - Biological Psychiatry: Global Open Science
JF - Biological Psychiatry: Global Open Science
IS - 4
ER -